文献速递肾移植

全国肾脏配对捐赠的受者与移植肾存活结局

Patient and Kidney Allograft Survival with National Kidney Paired Donation.
PubMed 文献 · Clin J Am Soc Nephrol · 2020-01-28

中位随访3.7年,经逆概率加权Cox回归调整后,配对捐赠受者的移植肾衰竭风险(aHR 0.95,95%CI 0.77-1.18,P=0.6)和死亡风险(aHR 0.86,95%CI 0.70-1.07,P=0.2)与对照组无显著差异。

要点

  • 全国配对捐赠受者移植肾衰竭与死亡风险与对照活体供肾移植受者相当。
  • 配对捐赠受者基线风险更高(女性、黑人、老年、公共保险等比例更高)。
  • 调整供受者及移植因素后,结局差异仍无统计学意义。

核心结论

  • 即使配对捐赠受者具有更多不良结局危险因素,其移植肾存活和患者生存与对照活体供肾移植受者等效。

研究设计与样本

  • 采用逆概率治疗加权Cox回归估计死亡删失的移植肾衰竭和死亡风险,模型调整受者、供者和移植因素。

主要发现

  • 全国肾脏登记处受者中女性、黑人、老年、公共保险、panel reactive antibodies >80%、透析时间更长及再次移植者比例更高。
  • 全国肾脏登记处受者中位随访3.7年(四分位距2.1-5.6,最长10.9年)。
  • 随访期间,全国肾脏登记处受者与对照组的移植肾衰竭发生率分别为5%和6%(log-rank P=0.2),死亡率分别为9%和10%(log-rank P=0.4)。
  • 调整后,移植肾衰竭风险无显著差异(aHR 0.95,95%CI 0.77-1.18,P=0.6),死亡风险亦无显著差异(aHR 0.86,95%CI 0.70-1.07,P=0.2)。

临床怎么用

  • 对于高免疫风险或难以找到相容供者的终末期肾病患者,全国配对捐赠可提供与常规活体供肾移植相当的长期结局。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: In the United States, kidney paired donation networks have facilitated an increasing proportion of kidney transplants annually, but transplant outcome differences beyond 5 years between paired donation and other living donor kidney transplant recipients have not been well described. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using registry-linked data, we compared National Kidney Registry (n=2363) recipients to control kidney transplant recipients (n=54,497) (February 2008 to December 2017). We estimated the risk of death-censored graft failure and mortality using inverse probability of treatment weighted Cox regression. The parsimonious model adjusted for recipient factors (age, sex, black, race, body mass index ≥30 kg/m2, diabetes, previous transplant, preemptive transplant, public insurance, hepatitis C, eGFR, antibody depleting induction therapy, year of transplant), donor factors (age, sex, Hispanic ethnicity, body mass index ≥30 kg/m2), and transplant factors (zero HLA mismatch). RESULTS: National Kidney Registry recipients were more likely to be women, black, older, on public insurance, have panel reactive antibodies >80%, spend longer on dialysis, and be previous transplant recipients. National Kidney Registry recipients were followed for a median 3.7 years (interquartile range, 2.1-5.6; maximum 10.9 years). National Kidney Registry recipients had similar graft failure (5% versus 6%; log-rank P=0.2) and mortality (9% versus 10%; log-rank P=0.4) incidence compared with controls during follow-up. After adjustment for donor, recipient, and transplant factors, there no detectable difference in graft failure (adjusted hazard ratio, 0.95; 95% confidence interval, 0.77 to 1.18; P=0.6) or mortality (adjusted hazard ratio, 0.86; 95% confidence interval, 0.70 to 1.07; P=0.2) between National Kidney Registry and control recipients. CONCLUSIONS: Even after transplanting patients with greater risk factors for worse post-transplant outcomes, nationalized paired donation results in equivalent outcomes when compared with control living donor kidney transplant recipients.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Leeser DB, Thomas AG, Shaffer AA, et al. Patient and Kidney Allograft Survival with National Kidney Paired Donation. Clin J Am Soc Nephrol. 2020. PMID: 31992572. doi:10.2215/CJN.06660619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。